Amphastar Pipeline Targets $10.5bn Market With Seven Generics

Company Performs Well On The Back Of Recently Launched Glucagon Rival

 
• By Akriti Seth
  
building pipeline
Amphastar has several generics and biosimilars in development • Source: Shutterstock

More from Products

More from Generics Bulletin